Scholarly Index
Aleix Prat
Hospital Clínic de Barcelona; 35,699 total citations; 814 total publications; best world rank #12
Hospital Clínic de Barcelona
35,699Total citations
814Total publications
90H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Breast Cancer Treatment Studies | Lifetime | 85 | ES 2 | 99.70 |
| Cancer Cells and Metastasis | Lifetime | 106 | ES 1 | 99.43 |
| HER2/EGFR in Cancer Research | Lifetime | 76 | ES 2 | 99.59 |
| Advanced Breast Cancer Therapies | Lifetime | 50 | ES 2 | 99.52 |
| Cancer Genomics and Diagnostics | Lifetime | 461 | ES 7 | 99.13 |
| Cancer Treatment and Pharmacology | Lifetime | 385 | ES 10 | 98.88 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 832 | ES 17 | 98.27 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 922 | ES 22 | 93.70 |
| Breast Cancer Treatment Studies | 2021-2025 | 12 | ES 1 | 99.82 |
| Monoclonal and Polyclonal Antibodies Research | 2021-2025 | 17 | ES 3 | 99.49 |
| HER2/EGFR in Cancer Research | 2021-2025 | 16 | ES 1 | 99.72 |
| Advanced Breast Cancer Therapies | 2021-2025 | 18 | ES 2 | 99.64 |
| Cancer Genomics and Diagnostics | 2021-2025 | 107 | ES 4 | 99.11 |
| Cancer Treatment and Pharmacology | 2021-2025 | 29 | ES 3 | 99.45 |
| Cancer Cells and Metastasis | 2021-2025 | 107 | ES 1 | 95.49 |
| Cancer-related Molecular Pathways | 2021-2025 | 134 | ES 3 | 92.33 |
| Cancer Research and Treatments | 2021-2025 | 666 | ES 7 | 81.87 |
| Estrogen and related hormone effects | 2021-2025 | 616 | ES 16 | 77.03 |